Monte-Carlo Simulation to Estimate the Health Care Costs Avoided With Fluticasone Furoate/Vilanterol Due to Exacerbation Rate Reduction in Spanish COPD Patients
Value Health
.
2014 Nov;17(7):A603.
doi: 10.1016/j.jval.2014.08.2095.
Epub 2014 Oct 26.
Authors
S Mayoralas
1
,
A Huerta
2
,
J Parrondo
2
,
C Rubio-Terrés
3
,
D Rubio-Rodríguez
3
Affiliations
1
Hospital Ramón y Cajal, Madrid, Spain.
2
GlaxoSmithKline, Madrid, Spain.
3
Health Value, Madrid, Spain.
PMID:
27202085
DOI:
10.1016/j.jval.2014.08.2095
No abstract available